Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2034-25-5

Post Buying Request

2034-25-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2034-25-5 Usage

Properties

1. Role: Intermediate in the synthesis of pharmaceuticals, agrochemicals, and dyes
2. Reagent: Commonly used in organic synthesis
3. Applications:
Organic Synthesis: Especially in the preparation of heterocyclic compounds and pharmaceuticals
Herbicides and Fungicides: Building block in their synthesis
Anti-tumor Potential: Subject of research for its pharmacological properties
4. Versatility: Wide range of applications in various industries

Check Digit Verification of cas no

The CAS Registry Mumber 2034-25-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,0,3 and 4 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 2034-25:
(6*2)+(5*0)+(4*3)+(3*4)+(2*2)+(1*5)=45
45 % 10 = 5
So 2034-25-5 is a valid CAS Registry Number.

2034-25-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-hydroxypentanehydrazide

1.2 Other means of identification

Product number -
Other names 5-hydroxy-pentanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2034-25-5 SDS

2034-25-5Relevant articles and documents

Karachanov et al.

, (1969)

Triazole derivatives: A series of Darapladib analogues as orally active Lp-PLA2 inhibitors

Wang, Kai,Xu, Wenwei,Zhang, Wei,Mo, Mingguang,Wang, Yiping,Shen, Jianhua

, p. 2897 - 2901 (2013/06/26)

This Letter reports our efforts towards the optimization of our previously identified series of imidazole and triazole derivatives that lead to the discovery of a series of orally active Lp-PLA2 inhibitors in C57 mice. These inhibitors are characterized by the presence of a diamine side chain in the molecules, such as 2c, 2f, and 4a. The introduction of the terminal-end amine succeeded in maintaining the in vitro activities at sub-nanomolar levels. The vivo activities could be greatly affected by variations in the two amines via modulating the metabolic stability and lipophilicity of the compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2034-25-5